Cargando…
Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Background: Chemotherapy-related cognitive impairment (CRCI), or “chemobrain,” isdefined as a phenomenon of cognitive deficits in cancer patients after chemotherapy and is characterized by deficits in areas of cognition, including memory, attention, speed of processing, and executive function, which...
Autores principales: | Durán-Gómez, Noelia, López-Jurado, Casimiro Fermín, Nadal-Delgado, Marta, Pérez-Civantos, Demetrio, Guerrero-Martín, Jorge, Cáceres, Macarena C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100963/ https://www.ncbi.nlm.nih.gov/pubmed/35566489 http://dx.doi.org/10.3390/jcm11092363 |
Ejemplares similares
-
Factors Related to Anxiety, Depressive Symptoms and Quality of Life in Breast Cancer
por: Cáceres, Macarena C., et al.
Publicado: (2022) -
Understanding Resilience Factors Among Caregivers of People with Alzheimer’s Disease in Spain
por: Durán-Gómez, Noelia, et al.
Publicado: (2020) -
Night Shift and Decreased Brain Activity of ICU Nurses: A Near-Infrared Spectroscopy Study
por: Durán-Gómez, Noelia, et al.
Publicado: (2021) -
Self-care nursing assessment: cross-cultural adaptation and validation of the Spanish version of the Self-care of chronic illness inventory
por: Durán-Gómez, Noelia, et al.
Publicado: (2023) -
The importance of early identification of infusion-related reactions to monoclonal antibodies
por: Cáceres, Macarena C, et al.
Publicado: (2019)